Blakey J D, Zaidi S, Shaw D E
Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Clin Exp Allergy. 2014 Aug;44(8):1023-32. doi: 10.1111/cea.12334.
Asthma attacks are a major global source of morbidity and cost. The incidence and impact of asthma attacks have not improved despite widespread adoption of effective universal treatment guidelines. Consequently, there is increasing interest in managing asthma based on specific assessments of both current symptoms and future risk. In this review, we consider 'risk' in asthma, and how it might be assessed from the patient's history and objective measurements. We also discuss the potential for encouraging shared decision-making and improving medical consensus through explicit communication of risk and highlight the potential opportunities and challenges in risk assessment to improve asthma management through individualised treatment strategies.
哮喘发作是全球发病和成本的主要来源。尽管广泛采用了有效的通用治疗指南,但哮喘发作的发病率和影响并未得到改善。因此,基于对当前症状和未来风险的具体评估来管理哮喘的兴趣日益增加。在本综述中,我们考虑哮喘中的“风险”,以及如何从患者病史和客观测量中进行评估。我们还讨论了通过明确传达风险来鼓励共同决策和改善医学共识的可能性,并强调了风险评估在通过个体化治疗策略改善哮喘管理方面的潜在机遇和挑战。